Apoptotic entities for use in treatment of neurodegenerative...

Details Apoptotic entities for use in treatment of neurodegenerative... Apoptotic entities for use in treatment of neurodegenerative...

A - Human Necessities

61

K

A61K 35/12 (2006.01) A61K 35/14 (2006.01) A61P 25/00 (2006.01) A61P 37/00 (2006.01)

Patent

CA 2409992

Treatment and/or prophylaxis, in mammalian patients, of neurodegenerative and other neurological medical disorders is effected by administering to the patient effective amounts of apoptotic bodies and/or apoptotic cells, preferably those derived from the patient's own white blood cells, e.g. by extracorporeal treatment of the patient's blood cells to induce apoptosis and administration of the apoptotic bodies and/or cells so formed to the patient.

La présente invention concerne le traitement et/ou la prophylaxie, chez des mammifères, de troubles neurodégénératifs et autres troubles pathologiques, consistant à administrer au patient des doses efficaces de corps et/ou de cellules apoptotiques, de préférence ceux provenant des propres globules blancs du patient, par exemple, en traitant extra-corporellement les globules blancs du patient pour entraîner l'apoptose et en administrant au patient les corps et/ou cellules apoptotiques ainsi obtenus.

Affiliated with

Also associated with

Rating

Apoptotic entities for use in treatment of neurodegenerative... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Apoptotic entities for use in treatment of neurodegenerative..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apoptotic entities for use in treatment of neurodegenerative... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1941307